JP2022526973A5 - - Google Patents
Info
- Publication number
- JP2022526973A5 JP2022526973A5 JP2021558911A JP2021558911A JP2022526973A5 JP 2022526973 A5 JP2022526973 A5 JP 2022526973A5 JP 2021558911 A JP2021558911 A JP 2021558911A JP 2021558911 A JP2021558911 A JP 2021558911A JP 2022526973 A5 JP2022526973 A5 JP 2022526973A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- ethyl
- isochromen
- hydroxypyridine
- pyrazolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19167245.0 | 2019-04-04 | ||
| EP19167245 | 2019-04-04 | ||
| PCT/EP2020/058168 WO2020200918A1 (en) | 2019-04-04 | 2020-03-24 | Isochromene derivatives as phosphoinositide 3-kinases inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526973A JP2022526973A (ja) | 2022-05-27 |
| JP2022526973A5 true JP2022526973A5 (enExample) | 2023-03-30 |
Family
ID=66092138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558911A Pending JP2022526973A (ja) | 2019-04-04 | 2020-03-24 | ホスホイノシチド３－キナーゼ阻害剤としてのイソクロメン誘導体 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US12527797B2 (enExample) |
| EP (1) | EP3947384B1 (enExample) |
| JP (1) | JP2022526973A (enExample) |
| KR (1) | KR20210149077A (enExample) |
| CN (1) | CN113874376A (enExample) |
| AR (1) | AR118588A1 (enExample) |
| AU (1) | AU2020252904A1 (enExample) |
| BR (1) | BR112021019589A2 (enExample) |
| CA (1) | CA3135309A1 (enExample) |
| DK (1) | DK3947384T3 (enExample) |
| ES (1) | ES2970530T3 (enExample) |
| FI (1) | FI3947384T3 (enExample) |
| HR (1) | HRP20240130T1 (enExample) |
| HU (1) | HUE065052T2 (enExample) |
| IL (1) | IL286937A (enExample) |
| MA (1) | MA55479A (enExample) |
| MX (1) | MX2021011979A (enExample) |
| MY (1) | MY206575A (enExample) |
| PH (1) | PH12021552402A1 (enExample) |
| PL (1) | PL3947384T3 (enExample) |
| PT (1) | PT3947384T (enExample) |
| SG (1) | SG11202110801XA (enExample) |
| SI (1) | SI3947384T1 (enExample) |
| TW (1) | TW202102504A (enExample) |
| WO (1) | WO2020200918A1 (enExample) |
| ZA (1) | ZA202107710B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024180207A1 (en) | 2023-03-02 | 2024-09-06 | Chiesi Farmaceutici S.P.A. | Pyridazinyl amino derivatives as alk5 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| PT1158958E (pt) | 1999-03-05 | 2007-08-13 | Chiesi Farma Spa | ''composições farmacêuticas em pó, melhoradas, para inalação'' |
| LT2496567T (lt) | 2009-11-05 | 2017-11-27 | Rhizen Pharmaceuticals S.A. | Nauji benzopirano kinazės moduliatoriai |
| TWI672297B (zh) | 2013-12-18 | 2019-09-21 | 義大利商吉斯藥品公司 | 作為磷脂肌醇－３－激酶抑制劑之異唏衍生物 |
| ES2750791T3 (es) | 2014-06-17 | 2020-03-27 | Chiesi Farm Spa | Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas |
| US9745308B2 (en) | 2014-09-12 | 2017-08-29 | Chiesi Farmaceutici S.P.A. | Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors |
| US9968604B2 (en) | 2015-04-16 | 2018-05-15 | Chiesi Farmaceutici S.P.A. | Chromene derivatives as phoshoinositide 3-kinases inhibitors |
| WO2017134053A1 (en) | 2016-02-04 | 2017-08-10 | Chiesi Farmaceutici S.P.A. | Pyrazole derivatives as phosphoinositide 3-kinases inhibitors |
-
2020
- 2020-03-24 EP EP20711985.0A patent/EP3947384B1/en active Active
- 2020-03-24 MA MA055479A patent/MA55479A/fr unknown
- 2020-03-24 US US17/600,676 patent/US12527797B2/en active Active
- 2020-03-24 FI FIEP20711985.0T patent/FI3947384T3/fi active
- 2020-03-24 MX MX2021011979A patent/MX2021011979A/es unknown
- 2020-03-24 DK DK20711985.0T patent/DK3947384T3/da active
- 2020-03-24 HR HRP20240130TT patent/HRP20240130T1/hr unknown
- 2020-03-24 MY MYPI2021005864A patent/MY206575A/en unknown
- 2020-03-24 HU HUE20711985A patent/HUE065052T2/hu unknown
- 2020-03-24 CA CA3135309A patent/CA3135309A1/en active Pending
- 2020-03-24 WO PCT/EP2020/058168 patent/WO2020200918A1/en not_active Ceased
- 2020-03-24 PT PT207119850T patent/PT3947384T/pt unknown
- 2020-03-24 JP JP2021558911A patent/JP2022526973A/ja active Pending
- 2020-03-24 ES ES20711985T patent/ES2970530T3/es active Active
- 2020-03-24 PH PH1/2021/552402A patent/PH12021552402A1/en unknown
- 2020-03-24 SI SI202030355T patent/SI3947384T1/sl unknown
- 2020-03-24 PL PL20711985.0T patent/PL3947384T3/pl unknown
- 2020-03-24 SG SG11202110801XA patent/SG11202110801XA/en unknown
- 2020-03-24 KR KR1020217033595A patent/KR20210149077A/ko not_active Withdrawn
- 2020-03-24 BR BR112021019589A patent/BR112021019589A2/pt not_active Application Discontinuation
- 2020-03-24 AU AU2020252904A patent/AU2020252904A1/en not_active Abandoned
- 2020-03-24 CN CN202080034539.2A patent/CN113874376A/zh active Pending
- 2020-03-27 TW TW109110464A patent/TW202102504A/zh unknown
- 2020-04-03 AR ARP200100946A patent/AR118588A1/es not_active Application Discontinuation
-
2021
- 2021-10-03 IL IL286937A patent/IL286937A/en unknown
- 2021-10-12 ZA ZA2021/07710A patent/ZA202107710B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3664492B2 (ja) | タチキニン ｎｋ▲下３▼ 受容体アンタゴニストとしてのキノリン誘導体 | |
| ES2315425T3 (es) | Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos. | |
| TWI398432B (zh) | Ｔａｓｋ-１及ｔａｓｋ-３離子通道之抑制劑 | |
| TWI526442B (zh) | 新的具有β２腎上腺素增效劑及Ｍ３毒蕈碱拮抗劑之活性的環己胺衍生物 | |
| JP4020954B2 (ja) | 疾患の処置のためのスルホンアミド誘導体 | |
| JP2005526741A5 (enExample) | ||
| JP2006514946A5 (enExample) | ||
| CN103402519A (zh) | 肿瘤治疗剂 | |
| JP2018529690A5 (enExample) | ||
| RU2014100744A (ru) | Лечение респираторных нарушений с помощью trpa1 антагонистов | |
| CN110267660A (zh) | 含布罗莫结构域蛋白4(brd4)的抑制剂 | |
| JP2018529657A5 (enExample) | ||
| JP2014523888A5 (enExample) | ||
| CN102202664A (zh) | 包含毒蕈碱性受体拮抗剂和β2肾上腺素受体激动剂的药物产品 | |
| TW201305130A (zh) | 突變雄激素受體拮抗藥 | |
| JP2018523644A5 (enExample) | ||
| US6951950B2 (en) | Quaternary ammonium compounds | |
| CA2573977A1 (en) | Nicotinic receptor agonists for the treatment of inflammatory diseases | |
| TW200813040A (en) | Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound | |
| CN110478344B (zh) | 一种酰基硫脲类化合物在制备抗乙型流感病毒药物中的应用 | |
| JP2012526767A (ja) | 癌及び線維性疾患の処置における新規な併用療法 | |
| JP2005516952A5 (enExample) | ||
| US20040138253A1 (en) | Quaternary ammonium compounds | |
| HRP20240130T1 (hr) | Derivati izokromena kao inhibitori fosfoinozitid 3-kinaza | |
| JP2023540740A (ja) | アデノシンａ２ｂ受容体アンタゴニストの共結晶 |